Clinical outcomes of breast cancer patients treated in phase I clinical trials at University of Colorado Cancer Center

Patients with metastatic breast cancer (MBC) refractory to standard of care therapies have a poor prognosis. The purpose of this study was to assess patient characteristics and clinical outcomes for patients with MBC treated on phase I clinical trials. We performed a retrospective review of all pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Jennifer A., Nicklawsky, Andrew, Kagihara, Jodi A., Gao, Dexiang, Fisher, Christine, Elias, Anthony, Borges, Virginia F., Kabos, Peter, Davis, Sarah L., Leong, Stephen, Eckhardt, Sue Gail, Diamond, Jennifer R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724484/
https://www.ncbi.nlm.nih.gov/pubmed/33063469
http://dx.doi.org/10.1002/cam4.3487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724484/
https://www.ncbi.nlm.nih.gov/pubmed/33063469
http://dx.doi.org/10.1002/cam4.3487

Ejemplares similares